Scope: Modulating β 2 -adrenergic receptor (β 2 -AR) expression and activation is important for maintaining skeletal muscle function. In this study, two food factors, resveratrol (RSV) and genistein (GEN), that are able to regulate β 2 -AR promoter activity and may improve skeletal muscle function are identified. Methods and results: Using luciferase reporter assay, 357 functional food factors as candidates for β 2 -AR promoter activity have been screened and subsequently RSV and GEN increase β 2 -AR promoter activity and β 2 -AR mRNA expression. Using promoter sequence analysis, it is shown that the CCAAT box and the GC box on the β 2 -AR promoter are required for the regulation of β 2 -AR expression by RSV or GEN. It is also ascertained that transcription factor NF-YA binds to the CCAAT box on the β 2 -AR promoter and that the amount of NF-YA bound to the CCAAT box is unchanged by RSV or GEN treatment. Finally, it is confirmed that a GEN-containing diet increases β 2 -AR expression in mouse skeletal muscle and increased skeletal muscle mass. Conclusions: The findings show that food-derived molecules have the potential to influence skeletal muscle mass and function by regulating G protein-coupled receptor expression.
Introduction
Maintaining skeletal muscle mass and function is vital for ameliorating the quality of life of elderly people. Skeletal muscle expresses several types of G protein-coupled receptors (GPCRs), members of a large family of seven-transmembrane receptors that transmit signals after perceiving systemic stimuli. Some of these receptors are known as potent inducers of hypertrophy. [1] Activation of Gαs-coupled receptors promotes increased adenylate cyclase activity and cyclic AMP (cAMP) levels. Intracellular cAMP enhances cAMP-response element binding protein
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(CREB) phosphorylation and CREB target gene expression, which is assumed to be critical for myogenic differentiation and myofiber survival. Gαi-coupled receptors activate both the PI3K-AKT and mTOR signaling pathway, [2] resulting in an increase in muscle protein synthesis. This evidence shows the importance of the regulation of the activation of GPCRs for the maintenance of skeletal muscle function.
β-2 Adrenergic receptor (β 2 -AR) is a GPCR expressed in skeletal muscle and its activation contributes to muscle hypertrophy. Previous studies have demonstrated that treatment with the β-adrenergic agonist formoterol results in increased muscle protein synthesis and muscle mass, [3] while administration of isoproterenol, another β-adrenergic agonist, increases the level of salt-inducible kinase (SIK1) protein leading to an acceleration of myogenesis in mice. [4] At the same time, activation of β-adrenergic signaling is supposed to be effective for the suppression of muscle atrophy. The synthetic β 2 -adrenergic agonist clenbuterol (CB) has been shown to exert a hypertrophic and anti-atrophic effect in mouse skeletal muscle, but not in β 2 -adrenergic receptor knockout mice. [5] These adrenergic agonists are assumed to be effective for improving skeletal muscle wasting diseases such as neuromuscular disease and muscular dystrophy. [6] Resveratrol (RSV), isolated from the roots of white hellebore (Veratrum grandiflorum (Maxim. ex Miq.) O. Loes), is a polyphenolic compound that has a variety of physiological properties, exhibiting antioxidant, anticancer, and anti-inflammatory www.advancedsciencenews.com www.mnf-journal.com effects. [7] It is known that RSV has several types of molecular target, including Sirtuin 1 (SIRT1), AMPK, and Nrf2. [8] Activation of SIRT1 (a member of the class Ⅲ histone deacetylase (HDAC) family) by RSV results in AMPK activation and improvement of mitochondrial biogenesis, [9, 10] an effect expected to be beneficial in preventing metabolic disorders. [11] Conversely, through in silico docking analysis, RSV has been shown to be an inhibitor of class I, II, and IV HDACs. [12] RSV is thought to function as an activator of a number of transcription factors: it acts as an estrogen receptor (ER) agonist, thereby increasing ER target gene expression [13] ; it promotes the expression of Nrf2 that exerts vasoprotective effects in endothelial cells [14] ; and it stimulates the transcriptional activities of CREB and ATF-2 being associated with the increased expression of CRE-responsive genes. [15] Genistein (GEN), an isoflavone found in soybean, is known as a potential anticancer compound that stimulates multiple signaling pathways. [16, 17] GEN has a tyrosine kinase inhibitory activity that is thought to produce its anticancer effect. [18] As is the case with RSV, GEN is involved in the activation of several transcription factors. It activates ERα as an estrogen-like ligand, thereby preventing skeletal muscle atrophy. [19, 20] GEN-ERβ interaction promotes the transcription driven by a general transcription factor Sp1 that recognizes the GC-rich DNA motif. [21] GEN also acts as a PPARγ agonist at higher doses [22] and stimulates transcription factor EB (TFEB) activity. [23] In recent years, it is has been reported that overexpression of β 2 -AR in mouse skeletal muscle using the adeno-associated virus vector increased skeletal muscle mass significantly, [24] suggesting that upregulation of β 2 -AR in skeletal muscle may promote muscle growth and maintain its favorable function. In this study, our aim was to discover functional food factors that enhance the expression of β 2 -AR in skeletal muscle.
Experimental Section

Reagents
RSV (purity > 99.0%) and GEN (purity > 98.0%) were purchased from TCI Chemicals. Clenbuterol hydrochloride (purity ࣙ 98.0%) and herbimycin A were purchased from LKT Laboratories. Actinomycin D, fulvestrant (ICI-182780), and anti-β-actin (A5441) antibody were purchased from Sigma-Aldrich. Dynabeads Protein G and Dynabeads M-280 Streptavidin were purchased from Thermo Fisher Scientific. Normal rabbit IgG and anti-acetyl-histone H3 (Lys9) antibody (C5B11) were purchased from Cell Signaling. Anti-nuclear factor-YA (NF-YA) antibody (ab6558) was purchased from Abcam. Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (10494-1-AP) was purchased from Proteintech.
Cell Culture
C2C12 cells were purchased from ATCC and maintained in medium A (DMEM supplemented with 100 units mL −1 of penicillin, 100 µg mL −1 of streptomycin, and 10% fetal bovine serum (FBS)). The cells were incubated at 37°C under 5% CO 2 .
Plasmid Constructs
Luciferase reporter plasmids for mouse β 2 -AR promoters were constructed by inserting an NheI/XhoI PCR fragment coding the 5 -promoter region of mouse β 2 -AR into the same restriction sites of the pGL4.10 vector. Point-mutated β 2 -AR promoter plasmids were synthesized using the overlap-extension PCR method.
Luciferase Assay
C2C12 cells were plated in 12-well plates at a density of 0.75 × 10 5 cells per well, cultured for 24 h, and transfected with 100 ng of β 2 -AR-Luc (a reporter plasmid) and 500 ng of pCMV-β-Gal (an expression plasmid for β-galactosidase) using the calcium phosphate method. After 24 h, the test compounds or control vehicle was added to the medium. All of the test compounds were dissolved in DMSO. After incubation for another 24 h, luciferase and β-galactosidase activities were determined as described previously. [25] Normalized luciferase values were determined by dividing the luciferase activity by the β-galactosidase activity.
Real-Time PCR
Total cell RNA was extracted using ISOGEN (NIPPON GENE) according to the manufacturer's instructions. A high capacity cDNA reverse transcription kit (Applied Biosystems) was used to synthesize and amplify cDNA from total RNA. Quantitative real-time PCR (SYBR green) was performed using an Applied Biosystems 7000 sequence detection system. Relative mRNA levels were determined by normalizing to the 18S transcript. The sequences of the primer sets used in this study were as follows: β 2 -AR, 5 -CAGGATTGCCTTTCAAGAGCTT-3 and 5 -TTGCTAGAGTAGCCGTTCCCAT-3 ; NF-YA, 5 -AGTCAGTGG AGGCCAGCTTA-3 and 5 -ATGATCTGCTGGGTTTGACC-3 ; I GF-1, 5 -GGTGGATGCTCTTCAGTTCGT-3 and 5 -AGTACATC TCCAGTCTCCTCAGATCA-3 ; and 18S, 5 -ACCGCAGCTAGG AATAATGGA-3 and 5 -GCCTCAGTTCCGAAAACCA-3 .
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) assay was performed according to the method of Saleh et al., with minor modifications. [26] C2C12 cells were seeded at 1 × 10 6 cells in 10-cm dishes in medium A to confluence, followed by treatment with vehicle or 100 µm of RSV or GEN for 24 h. Cells were cross-linked, resuspended by sonication (Handy Sonic UR-21P; Tomy Seiko, Tokyo, Japan) 16 times for 10 s to generate an average of 400-500 bp DNA fragments. Supernatants were precleared by incubation with Dynabeads Protein G (Invitrogen) for 1 h at 4°C and incubated with 5 µg of normal rabbit IgG, anti-acetyl-histone H3, or anti-NF-YA antibody overnight at 4°C. Immunoprecipitated complexes were captured by 3 h incubation at 4°C with Dynabeads Protein G. Immunoprecipitated complexes and 10% input controls were eluted and DNA was www.advancedsciencenews.com www.mnf-journal.com extracted by phenol-chloroform extraction, resuspended in 30 µm TE (Tris-EDTA buffer) and quantified by real-time PCR.
Avidin-Biotin-Conjugated DNA-Binding Assay
Avidin-biotin-conjugated DNA-binding (ABCD) assay was performed according to the method of Daitoku et al., with minor modifications. [27] C2C12 cells treated with 100 µm of RSV or GEN for 3 h were lysed with lysis buffer (20 mm Hepes (pH 7.5), 100 mm KCl, 0.1% Triton X-100, 0.5 mm EDTA, and protease inhibitors), and the whole-cell extracts were precleared by incubation with biotinylated double-stranded unconcerned oligonucleotides (−289/−260) immobilized on Dynabeads M-280 streptavidin (Invitrogen) for 30 min at 4°C. Precleared samples were incubated with biotinylated double-stranded oligonucleotides containing CCAAT box (−307/−278) or mutated CCAAT box (−307/−278-mut) immobilized on Dynabeads M-280 streptavidin for 30 min at 4°C. The beads were washed three times and DNA-bound proteins were analyzed by western blotting. The following oligonucleotides biotinylated at 3 -end of the sense strand were used: −289/−260, CCCAAAGTTGTTGCACGT-CACTGGGCAATT; −307/−278, ATCCGGCCGTGCCATTGGC-CCAAAGTTGTT; and −307/−278-mut, ATCCGGCCGTGCCC-GACTCCCAAAGTTGTT.
Western Blotting
Samples were boiled with Laemmli sample buffer for 5 min at 95°C. The samples were electrophoresed through a reduced SDS-PAGE (10% polyacrylamide gel). After electrophoresis, the gel was transblotted onto a polyvinylidene difluoride membrane and incubated with 0.25% polyvinylpyrrolidone (Sigma, St. Louis, MO, USA) in TBS/T (Tris-buffered saline containing 10% Tween 20) for blocking, washed, and treated with the primary antibodies overnight at 4°C. After washing with TBS/T, the blots were further incubated for 1 h at room temperature with the horseradish peroxidase (HRP)-linked secondary anti-IgG antibody. The membranes were visualized by Amersham Biosciences ECL Western blotting detection reagent (GE Healthcare Life Sciences). Data acquisition and analysis were performed using an ImageQuant LAS 4000 system (GE Healthcare and Life Sciences).
Mice
All experiments were performed according to the guidelines of the Animal Usage Committee of the Faculty of Agriculture, University of Tokyo (Tokyo, Japan) and were approved by the committee (Permission No. P11-590). Male 7-week-old C57BL/6J mice obtained from Clea Japan were housed in the animal care facility under controlled temperature and humidity conditions with a 12-h light/dark cycle. For oral administration of 5, 20, and 50 mg kg -1 body weight of RSV or GEN, mice were treated by oral gavage with 10 µL g -1 body weight of 0.5, 2, and 5 mg mL -1 of RSV or GEN (20% DMSO in PBS) once a day for 4 days. Gastrocnemius muscles were collected 4 h after last treatment. For administration of GEN-containing diet, mice were fed a 20% casein diet or a 20% casein diet containing 0.1% (w/w) GEN for 14 days. During this period, mice were injected intraperitoneally with 2 mg kg -1 body weight of clenbuterol (CB) diluted in sterile water (100 µL per mouse) every other day. At 14 days after the initiation of feeding, mice were killed under isoflurane anesthesia, and tibialis anterior (TA) muscles were rapidly excised, frozen in liquid nitrogen, and stored at −80°C until further processing.
Statistical Analysis
All data are presented as mean ± SD. Statistical significance was evaluated by using unpaired two-tailed Student's t-test or, when appropriate, Dunnett's or Tukey's HSD test. Data are representative of at least three individual experiments.
Results
Food Factors That Enhance β 2 -AR Gene Expression
To assess food factors that boost β 2 -AR promoter activity, we performed luciferase assays using a reporter gene positioned within −1500 to +1 nucleotides of the mouse β 2 -AR promoter region. A total of 357 purified in-house food factors were used as test compounds. [28] C2C12 myoblast cells were transfected with the reporter plasmid and then cultured with one of the food factors at 100 µm for 24 h. Subsequently, we selected food factors that fulfilled the following requirements: 1) those that elevated luciferase activity more than 2.5-fold compared to the control group and 2) those that elevated endogenous β 2 -AR mRNA levels in the C2C12 cells. We finally identified RSV and GEN as potential activators of β 2 -AR gene expression ( Figure 1A) . Luciferase activity was increased by RSV and GEN in a dose-dependent manner, becoming significant at ࣙ50 µm for RSV and ࣙ10 µm for GEN ( Figure 1B) .
To confirm the effects of RSV or GEN for β 2 -AR mRNA expression levels, we confirmed whether food factors increased β 2 -AR expression irrespective of differentiation stage of the C2C12 cells beforehand (Figure 1 , Supporting Information). As a results, RSV and GEN increased β 2 -AR expression both undifferentiated and differentiated C2C12 cells. β 2 -AR expression was increased with myotube differentiation, so the effects of RSV or GEN were confirmed more definitely in undifferentiated cells. Therefore, we used undifferentiated C2C12 cells in subsequent experiments. β 2 -AR gene expression was also raised by RSV and GEN in a dose-dependent manner, becoming significant at ࣙ25 µm for both ( Figure 1C) . Additionally, incubation times shorter than 24 h (3 or 6 h) with RSV or GEN were sufficient to significantly increase endogenous β 2 -AR mRNA levels ( Figure 1D ).
Mechanism of Increase in β 2 -AR Promoter Activity by RSV or GEN
To examine whether RSV or GEN increases the β 2 -AR mRNA levels by stabilizing it, C2C12 cells were pretreated with actinomycin D, a potent transcription inhibitor, for 30 min and then treated with RSV or GEN for 2, 4, or 6 h. Levels of β 2 -AR mRNA diminished over time, and turnover rate was not prolonged by RSV or GEN, suggesting that stability of β 2 -AR mRNA was not affected by these food factors (Figure 2) .
To test whether the tyrosine kinase inhibition activity of GEN is involved in the regulation of β 2 -AR expression, we examined the effects of herbimycin, a known tyrosine kinase inhibitor, on the activation of the β 2 -AR promoter. The reporter assay revealed that β 2 -AR promoter (−1500/+1) activity was not altered by the herbimycin treatment ( Figure 3A) . Since both RSV and GEN are ER agonists, we investigated the possibility that ER caused the elevation of β 2 -AR promoter activity. An ER antagonist ICI-182780 had no effect on the increase of β 2 -AR mRNA level induced by RSV or GEN ( Figure 3B and C) . In addition, reporter assays confirmed that β 2 -AR promoter activity was not increased by estradiol (Figure 2, Supporting Information) . These results indicate that the effects of RSV and GEN are unrelated to their ER agonistic activity.
To determine what functional elements are required for β 2 -AR promoter (−1500/+1) activation induced by RSV and GEN, four 5'-deletion versions of mutants (−750/+1, −400/+1, −300/+1, and −200/+1) were constructed. Compared to a DMSO-treated group, luciferase activity was significantly increased by RSV and GEN in the cells expressing −1500/+1, −750/+1, and −400/+1 reporter plasmids (Figure 4) . Promoter activity was modestly increased, although not significantly different, for the −300/+1 reporter plasmid, and unchanged for the −200/+1 reporter plasmid, suggesting that the promoter region from −400 to −200 is important for regulation by RSV and GEN.
Importance of CCAAT Box for β 2 -AR Promoter Activation by RSV and GEN
On the basis of the promoter activity results, we subsequently focused on the region from −300 to −200 bp as the likely location for promoter activation by RSV and GEN. We constructed progressively shortened promoter constructs between −300 and −200 bp and conducted further reporter assays. We confirmed that although −300/+1 promoter activity was increased significantly by the treatment of RSV or GEN, shorter promoter constructs (−286/+1, −275/+1, −260/+1, −246/+1, −226/+1, and −200/+1) were not activated ( Figure 5A ). This suggested that the region from −300 to −286 bp contained the regulatory domains. This region contains the CCAAT box (−294/−290), which is conserved among mouse, human, and rat β 2 -AR promoter sequences ( Figure 5B ). We prepared a construct containing a mutated CCAAT region (−300/+1 mut; Figure. 5C ) and confirmed that activation of luciferase activity of the promoter (−300/+1) by RSV or GEN was absent ( Figure 5D ). This result suggests that the CCAAT box (−294/−290) is important for the activation of β 2 -AR by RSV and GEN.
Importance of NF-YA for β 2 -AR Expression
NF-YA is considered to bind to the CCAAT box, [29] so we confirmed that NF-YA is expressed in mouse skeletal muscle (unpublished data) and C2C12 cells (Figure 3 , Supporting Information). The expression of NF-YA was not affected by treatment with RSV or GEN in C2C12 cells. To assess whether NF-YA binds to the CCAAT box on β 2 -AR promoter and is affected by RSV or GEN treatment, we conducted ChIP assays. Two primer pairs were used for ChIP quantification; one corresponded to −467 to −260 bp covering the CCAAT box and the other primer pair corresponded to −5085 to −4967 bp, the distal promoter region ( Figure 6A) . The ChIP assay revealed that NF-YA could bind to the promoter region of β 2 -AR including the CCAAT box (−294/−290) ( Figure 6B ), and neither RSV nor GEN treatment altered the recruitment of NF-YA to the promoter region of β 2 -AR. Although RSV and GEN slightly increased the recruitment of acetyl-histone H3, it was not statistically significant. We also confirmed that NF-YA and acetyl-histone H3 did not bind to the distal region of the β 2 -AR promoter.
To confirm that NF-YA binds to the CCAAT box on the β 2 -AR promoter sequence, ABCD assay was also employed. Precipitation using a biotinylated 30 bp double-stranded DNA containing either the CCAAT box or mutated CCAAT box was performed using streptavidin-coated magnetic beads. Beforehand, we confirmed the endogenous NF-YA was detectable at about 38 kD in western blotting (Figure 4 , Supporting Information). Western blot of immunoprecipitated samples showed that endogenous NF-YA was recruited to the β 2 -AR promoter sequence containing the CCAAT box but the binding of NF-YA to CCAAT-containing β 2 -AR promoter sequence was not increased in RSV-or GENtreated samples ( Figure 6C ). In the control experiment, a mutated CCAAT box did not precipitate NF-YA. β-Actin was used as loading controls of input samples.
Importance of GC Box for β 2 -AR Promoter Activation by GEN
Next, we investigated the importance of the region from −400 to −300 bp as the likely location for promoter activation by GEN. Since luciferase activation by RSV showed no variation between −300/+1 and −400/+1 plasmids after repeated assay, we concluded that the regulatory element of β 2 -AR by RSV was located from −300 to −200 bp and not in the region from −400 to −300 bp ( Figure 4A ). (D) , the DMSO-treated group for each reporter plasmid was set to 1. In (A), differences were analyzed by Dunnett's test among the RSV or GEN treated group (n = 6); ** p < 0.01 versus pGL4.10-expressed group. In (C), differences were analyzed by Tukey's HSD test among the RSV or GST treated group. Different letters above bars indicate a significant difference (p < 0.01).
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Reporter assay using progressively shortened promoter plasmids revealed that −400/+1 and −386/+1 promoter plasmids were activated significantly by GEN treatment compared to −300/+1 promoter plasmid ( Figure 7A) . The region from −400 to −367 bp contains the GC-rich region (GC box), a binding region of transcription factors, and is highly conserved among species ( Figure 7B ). Luciferase assay using constructs containing a mutation of GC box (−400/+1-mut; Figure 7C ) revealed that the promoter containing the mutated GC box was not activated by GEN ( Figure 7D ).
CRE is Not Related to Modulating β 2 -AR Expression
We tested whether the β 2 -AR promoter mutated in the CRE (−276/−269) is activated by RSV or GEN, because both RSV and GEN are involved in CREB activation. [30, 31] We prepared four mutated 400 bp promoter plasmids: CCAAT mutant, GC mutant, CRE mutant, and CCAAT/GC double mutant ( Figure 8B) . β 2 -AR promoter activation by RSV or GEN was not affected by the mutation of CRE ( Figure 8C ). In GEN treatment groups, both the CCAAT and GC mutant promoters showed significantly reduced luciferase activity and the CCAAT/GC double-mutated promoter showed synergistically reduced activity compared to CCAAT or GC individually.
GEN Affects Skeletal Muscle Through Increased β 2 -AR Expression in Mice
First, we examined whether gavage administration of the RSV or GEN solution affects β 2 -AR expression in skeletal muscle of mice. Daily administration of 50 mg kg -1 of RSV or 5 mg kg -1 of GEN for 4 days made a significant increase in the β 2 -AR mRNA levels in skeletal muscle (Figure 9A and B) . These results suggest that GEN has a more potent activity to induce increased β 2 -AR expression in vivo than RSV. To verify the functional effect of GEN on skeletal muscle in vivo, mice were fed a 20% casein diet containing 0.1% GEN for 14 days; and to confirm the augmenting effect of increasing β 2 -AR expression level by GEN, mice were intraperitoneally injected with clenbuterol (CB) twice a day during the feeding period. The mice were divided into four groups: a) control diet + control injection; b) control diet + CB injection;(c) GEN diet + control injection; and d) GEN diet + CB injection. Body weight and food intake were not affected by dietary GEN supplementation ( Figure 5 , Supporting Information), indicating that the 0.1% GEN-containing diet had no toxic effect. TA muscle weight was increased significantly in group (d) mice (GEN diet + CB injection) compared to group (a) mice (control diet + control injection; Figure 9C ). We collected total RNA from TA muscles and β 2 -AR expression was determined. GEN diet groups had a trend toward increasing β 2 -AR expression, but it was not significant ( Figure 9D ). β 2 -AR expression in TA muscles was not affected by the injection of CB. In addition, we confirmed the protein level of β 2 -AR in skeletal muscle. We previously affirmed that β 2 -AR could be detected at about 53 kD in western blotting by mouse β 2 -AR-overexpressing HEK293 cells (Figure 6 , Supporting Information). As is the case with mRNA, GEN diet group showed increased tendency of β 2 -AR protein level ( Figure 9E) . Moreover, insulin-like growth factor (IGF-1) expression was increased significantly in (d) GEN diet + CB injection group compared to (c) GEN diet + control injection group ( Figure 9F ).
Discussion
In this study, our aim was to discover functional food factors that enhance mouse β 2 -AR promoter activity and improve skeletal muscle function. Among 357 food compounds tested, several likely candidates emerged, with RSV and GEN being identified as the two most potent. This novel finding illustrates the possibility that regulation of the expression of human β 2 -AR by food factors may be achievable.
Considering that both RSV and GEN enhanced β 2 -AR gene expression without affecting mRNA stability (Figure 2 ), these compounds would appear to be effective at the transcriptional level. In addition, RSV and GEN increased the β 2 -AR mRNA level after only 3 h treatment ( Figure 1D ). Since this time period is thought to be too short to cause an increase in transcription factors that might in turn increase mRNA levels, we speculated that RSV and GEN were acting directly to affect the activity of some transcription factors required for β 2 -AR gene expression. Figure 7 . Identification of the GEN-response element of the β 2 -AR promoter upstream region between -400 and -300. A) Luciferase activity of promoter transfected cells treated with 100 µm of GEN. A value of 1 was set for the DMSO-treated group. B) DNA sequences of mouse, human, and rat β 2 -AR promoters around the GC box, and oligonucleotide sequences containing wild-type or mutated GC box of β 2 -AR. Conserved DNA sequences are marked by asterisks. C) Map of the reporter plasmids used in (D). D) Luciferase activity of promoter transfected cells treated with vehicle or 100 µm of GEN. The DMSO-treated group for each reporter plasmid was set to 1. In (A) and (D), different letters above bars indicate a significant difference (p < 0.01) according to Tukey's HSD test (n = 6).
As noted in the introduction, both RSV and GEN have multiple activities that bring about physiological effects. GEN is known as a tyrosine kinase inhibitor, a property considered to be crucial for its action. However, our results clearly indicate that tyrosine kinase is not involved in regulating β 2 -AR gene expression ( Figure  3A) . We also demonstrated that the ER agonistic activity of RSV and GEN had no effect on promoter activation (Figure 3B and C; Figure 2 , Supporting Information). The β 2 -AR promoter contains a cAMP response element (CRE) in the region from 276 to 269 bp, which is thought to be important for the regulation of its expression, [32] and both RSV and GEN are known to be CREB activators. [30, 31] We affirmed that both RSV and GEN increased the activity of the CRE-driven reporter, CRE-Luc (unpublished data). Unexpectedly, β 2 -AR promoter (−1500/+1) activity was not increased by forskolin or cAMP analogs (unpublished data), and mutation of the CRE motif did not affect the promoter activation driven by RSV or GEN ( Figure 8C ). We concluded that neither the CRE motif nor the activation of cAMP signaling were the mechanisms through which RSV and GEN exert their stimulation effect on β 2 -AR gene expression.
Previous studies showed that several stimuli increase β 2 -AR gene expression, and proposed the responsive promoter regions and potential transcription factors as mechanisms. Dexamethasone treatment has been reported to transiently increase the β 2 -AR mRNA level in human airway epithelial cells. [33] In contrast, we found that the β 2 -AR promoter (−1500/+1) activity was not increased by dexamethasone treatment (unpublished data). In addition, it has been reported that C/EBPα binds to the rat β 2 -AR promoter region (−933/−925) and downregulates its expression. [34] Our finding, that the mouse β 2 -AR promoter (−750/+1) activity was increased by RSV and GEN, rules out the possibility of C/EBPα involvement.
Our reporter assays, using a number of truncated versions of the β 2 -AR promoter gene, narrowed down the region important for increasing the promoter activity to between −400 and −200 bp (Figure 4) . We confirmed that the CCAAT box is critical for regulation by RSV and GEN ( Figure 5D ), and the GC box indispensable for the regulation by GEN ( Figure 7D ). Although the presence of the CCAAT and GC boxes has been shown in the human and rat β 2 -AR promoter region, [35, 36] the significance of these motifs for β 2 -AR gene expression has not yet been discussed. In the current study, we showed that the GC box plays a key role in activation of the β 2 -AR promoter caused by GEN, but did not clarify potential transcription factors responsible for the regulation (Figure 7 ). Further analysis is needed to unveil the underlying molecular mechanism by which GEN increases β 2 -AR gene expression in a GC box-dependent manner.
NF-Y is a ubiquitously expressed transcription factor composed of trimeric subunits, NF-YA, NF-YB, and NF-YC. ChIP and ABCD assay revealed that NF-YA binds to the CCAAT box in the Figure 9 . Dietary GEN-induced increase of β 2 -AR expression in skeletal muscle enhances the effect of a β 2 -AR agonist. A and B) Orally administrated RSV and GEN increase β2-AR expression in skeletal muscle. Mice were treated RSV or GEN (5, 20 , and 50 mg kg -1 p.o.) once a day for 4 days (n = 3) and relative β 2 -AR mRNA levels in muscle were evaluated using RT-PCR. C-E) C57BL/6J mice fed 0.1% GEN diet for 14 days (n = 5-6). During the same period, mice were intraperitoneally injected with CB (2 mg kg -1 of body weight) every other day. C) Tibialis anterior (TA) weight. D) mRNA and (E) protein levels of β 2 -AR in TA muscle. F) IGF-1 mRNA levels in TA muscle. In (A) and (B), differences were analyzed by Dunnett's test ( * p < 0.05). In (C) and (F), differences were analyzed by Tukey's HSD test ( ** p < 0.01).
www.advancedsciencenews.com www.mnf-journal.com β 2 -AR promoter ( Figure 6B, C) , but unexpectedly the amount of NF-YA binding to this motif was not increased by RSV or GEN. Previously, it has been reported that several transcriptional factors and cofactors, such as p53 and p300, bind NF-YA, thereby promoting transcriptional activity of NF-YA. [37, 38] Protein modification, such as ubiquitination and acetylation, is proposed as the basis for the regulation of the transcriptional activity of NF-YA. [39] Taken together, it seems likely that RSV and GEN increase β 2 -AR gene expression by modulating NF-YA transcriptional activity, not by increasing the amount of NF-YA recruited to this motif.
We went on to test whether dietary GEN induces β 2 -AR expression in skeletal muscle and contributes to muscle anabolism in mice. Beforehand, we examined the effect of oral treatment of RSV and GEN in mice for a short period (once daily for 4 days) and confirmed that both increased the β 2 -AR mRNA level in the gastrocnemius, though levels increased significantly more with GEN ( Figure 9A and B) . Therefore, we decided to examine the additive effect of dietary GEN when mice were injected with a synthesized β 2 -AR agonist, CB.
The importance of the amount of β 2 -AR for regulation of muscle mass was previously evidenced. [24] The authors reported that the increased expression of exogenous β 2 -AR mediated by the adenovirus vector caused a rise in skeletal muscle mass. In our experiments, gavage administration of the GEN solution for 4 days caused a significant increase in the β 2 -AR mRNA levels in skeletal muscle ( Figure 9B ), but there was just a trend toward an increase in β 2 -AR expression by administration of the GEN diet for 14 days ( Figure 9D and E). The GEN diet together with CB injection caused a statistically significant increase in muscle mass with an accompanying rise in IGF-1 mRNA levels despite no statistically significant changes in the β 2 -AR mRNA and protein levels ( Figure 9C-F) . To verify the functional effect of GEN on muscle mass, further in vivo experiments, for example, with a longer-term feeding or a combination of physical exercise should be performed.
It has been reported that CB treatment increases insulin-like growth factor (IGF-1) concentration in rat skeletal muscle, [40] leading to hypertrophy. [41] Our results show that the IGF-1 mRNA levels were significantly increased by CB injection in GEN-treated group ( Figure 9F ), however, a direct causal association was not demonstrated. A previous study reported an increase in IGF-1 expression in rat soleus muscle subjected to CB-containing drinking water for 3 days, and a return to a prior level at day 9. [40] At this point we cannot clarify the reason why CB did not cause a significant increase in IGF-1 expression in the control diet group. We also found that only GEN treatment ( Figure 9F , the group c) failed to increase IGF-1 expression. This suggests that a significant increase in the IGF-1 mRNA levels might require increased β 2 -AR expression along with a supply of its ligand. Since the ER agonist activity of isoflavones is widely acknowledged to contribute to increasing muscle mass and preventing atrophy, [20, 42] multiple activities of GEN in addition to increasing β 2 -AR gene expression may be involved in improving skeletal muscle mass.
It has been widely accepted that activation of muscle β 2 -AR by a synthesized agonist leads to muscle hypertrophy. Indeed, use of the synthesized agonist clenbuterol by athletes is strictly prohibited, and would be considered a doping violation. Therefore, increasing muscle β 2 -AR expression via food factors (by dietary improvement) is thought to be a promising strategy for achieving muscle hypertrophy. In the current study, we show that RSV and GEN increase the β 2 -AR mRNA levels in skeletal muscle cells. The suggested mechanism by which these compounds increase β 2 -AR gene expression is by modulating β 2 -AR promoter activity, and beneficial effects for maintaining skeletal muscle could be achieved via dietary supplements. Further research on RSV and GEN is needed to reveal their precise regulatory mechanisms, and how as food factors they may act beneficially to maintain skeletal muscle mass.
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